Quantcast

Latest The Institute of Cancer Research Stories

2014-07-10 12:16:31

Biotechnology and Biological Sciences Research Council A network of signals active in almost all types of cancer sends the protein factories in our cells into overdrive, and may help fuel a tumor's uncontrolled growth, new research suggests. Scientists at The Institute of Cancer Research, London, identified a molecular trigger responsible for ratcheting up activity of the endoplasmic reticulum (ER) – the cellular factory that makes the building blocks cancer cells need to keep...

2014-04-18 12:13:08

Scientists have identified the first genetic variant specifically associated with the risk of a difficult-to-diagnose cancer sub-type accounting for around 10-15 per cent of all breast cancer cases. The largest ever study of the breast cancer sub-type, called invasive lobular carcinoma, gives researchers important clues to the genetic causes of this particular kind of breast cancer, which can be missed through screening. The research, published today (Thursday) in the journal PloS...

2014-02-28 14:12:15

Early humans may have evolved black skin to protect against a very high risk of dying from ultraviolet light (UV)-induced skin cancer, a new analysis concludes. Skin cancer has usually been rejected as the most likely selective pressure for the development of black skin because of a belief that it is only rarely fatal at ages young enough to affect reproduction. But a new paper, published in Proceedings of the Royal Society B, cites evidence that black people with albinism from parts of...

2013-12-02 21:15:20

Scientists have described a new family of proteins that appear to play a key role in cancer and might be targets for future cancer drugs. A major new study in the journal Nature sets out the structure of the new family, called glutamate intramembrane proteases – the founding member of which plays a critical role in transforming healthy cells into cancer cells. The research, funded by Cancer Research UK and conducted by scientists at The Institute of Cancer Research, London, defined...

2013-08-30 12:49:41

Collagen, the stuff of ligaments and skin, and the most abundant protein in the human body, has an extraordinary role in triggering chemical signals that help protect the body from cancer, a new study reveals. Scientists at The Institute of Cancer Research, London, have uncovered a series of chemical signals sent out by collagen that appear to protect against cancer's growth. Boosting those signals could act as an effective treatment for cancers that grow in the presence of collagen,...

2013-08-19 13:11:48

A gene that helps control the aging process by acting as a cell's internal clock has been linked to cancer by a major new study. Scientists at The Institute of Cancer Research, London, found a genetic variant that influences the aging process among four new variants they linked to myeloma – one of the most common types of blood cancer. The study more than doubles the number of genetic variants linked to myeloma, bringing the total number to seven, and sheds important new light on the...

2012-07-11 14:47:35

A new drug combination could offer hope to children with neuroblastoma — one of the deadliest forms of childhood cancer — by boosting the effectiveness of a promising new gene-targeted treatment. Researchers at The Institute of Cancer Research in London have found a way to overcome the resistance of cancer cells to a drug called crizotinib, which recently showed positive early results in its first trial in children with cancer. Crizotinib has already been licensed by the US...

2009-12-16 07:00:00

LOS ALTOS, Calif., Dec. 16 /PRNewswire/ -- IronKey, maker of the world's most secure flash drives, today announced that it is providing The Royal Marsden Hospital with its secure, managed USB flash drives to protect data in transit. The Royal Marsden encourages its staff to avoid carrying data on portable devices unless absolutely necessary. To avoid any ambiguity when they do, its policy states that it must be on an IronKey. The Royal Marsden is committed to promoting excellence in...

2008-10-07 03:00:23

Cancer drug developer Antisoma (LSE: ASM; USOTC: ATSMY), The Institute of Cancer Research (The Institute) and Cancer Research Technology (CRT) today announced a collaboration and licensing agreement under which Antisoma has acquired rights to develop and commercialise novel anti-cancer compounds called PPM1D (protein phosphatase magnesium-dependent 1 d) inhibitors. Work carried out at the Breakthrough Breast Cancer Research Centre and at the Cancer Research UK Centre for Cancer...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.